Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J, Klein J U, Lee R J, Segall J E, Westwick J K, Der C J, Pestell R G
Department of Pharmacology, The University of Western Australia, Nedlands, Western Australia 6907, Australia.
J Biol Chem. 1999 Sep 3;274(36):25245-9. doi: 10.1074/jbc.274.36.25245.
The small GTP-binding protein Rac1, a member of the Ras superfamily, plays a fundamental role in cytoskeleton reorganization, cellular transformation, the induction of DNA synthesis, and superoxide production. Cyclin D1 abundance is rate-limiting in normal G(1) phase progression, and the abundance of cyclin D1 is induced by activating mutations of both Ras and Rac1. Nuclear factor-kappaB (NF-kappaB) proteins consist of cytoplasmic hetero- or homodimeric Rel-related proteins complexed to a member of the IkappaB family of inhibitor proteins. In the current studies, activating mutants of Rac1 (Rac(Leu-61), Rac(Val-12)) induced cyclin D1 expression and the cyclin D1 promoter in NIH 3T3 cells. Induction of cyclin D1 by Rac1 required both an NF-kappaB and an ATF-2 binding site. Inhibiting NF-kappaB by overexpression of an NF-kappaB trans-dominant inhibitor (nonphosphorylatable IkappaBalpha) reduced cyclin D1 promoter activation by the Rac1 mutants, placing NF-kappaB in a pathway of Rac1 activation of cyclin D1. Specific amino acid mutations in the amino-terminal effector domain of Rac(Leu-61) had comparable effects on NF-kappaB transcriptional activity and activation of the cyclin D1 promoter. The NF-kappaB factors Rel A (p65) and NF-kappaB(1) (p50) induced the cyclin D1 promoter, requiring both the NF-kappaB binding site and the ATF-2 site. Stable overexpression of Rac(Leu-61) increased binding of Rel A and NF-kappaB(1) to the cyclin D1 promoter NF-kappaB site. Activation of Rac1 in NIH 3T3 cells induces both NF-kappaB binding and activity and enhances expression of cyclin D1 through an NF-kappaB and ATF-2 site in the proximal promoter, suggesting a critical role for NF-kappaB in cell cycle regulation through cyclin D1 and Rac1.
小GTP结合蛋白Rac1是Ras超家族的成员之一,在细胞骨架重组、细胞转化、DNA合成诱导及超氧化物生成中发挥着重要作用。细胞周期蛋白D1的丰度在正常G1期进程中起限速作用,且细胞周期蛋白D1的丰度可由Ras和Rac1的激活突变诱导产生。核因子-κB(NF-κB)蛋白由与IkappaB家族抑制蛋白成员复合的细胞质异源或同源二聚体Rel相关蛋白组成。在当前研究中,Rac1的激活突变体(Rac(Leu-61)、Rac(Val-12))在NIH 3T3细胞中诱导了细胞周期蛋白D1的表达及细胞周期蛋白D1启动子活性。Rac1诱导细胞周期蛋白D1表达需要一个NF-κB结合位点和一个ATF-2结合位点。通过过表达NF-κB反式显性抑制剂(非磷酸化的IkappaBalpha)抑制NF-κB,可降低Rac1突变体对细胞周期蛋白D1启动子的激活作用,这表明NF-κB参与了Rac1激活细胞周期蛋白D1的信号通路。Rac(Leu-61)氨基末端效应结构域中的特定氨基酸突变对NF-κB转录活性及细胞周期蛋白D1启动子的激活具有类似影响。NF-κB因子Rel A(p65)和NF-κB(1)(p50)诱导细胞周期蛋白D1启动子活性,这需要NF-κB结合位点和ATF-2位点。稳定过表达Rac(Leu-61)可增加Rel A和NF-κB(1)与细胞周期蛋白D1启动子NF-κB位点的结合。在NIH 3T3细胞中激活Rac1可诱导NF-κB结合及活性,并通过近端启动子中的NF-κB和ATF-2位点增强细胞周期蛋白D1的表达,这表明NF-κB在通过细胞周期蛋白D1和Rac1进行的细胞周期调控中起关键作用。